In United States ex rel. Franklin v. Parke-Davis, What was the alleged false claim? Who submitted it? What was the connection between the defendants' conduct and the false claim? What does the court mean what it says that there is "no double falsehood requirement"? What would the result in the case be if the defendant could show that states were willing to reimburse providers for the off-label uses at issue? Also, In United States ex rel. Brown v. Celgene Corporation, what specific conduct by Celgene formed the basis of the off-label promotion allegations? What specific conduct was alleged in the Celgene complaint that was not included in the "Covered Conduct" that was resolved under the settlement agreement?

Answer rating: 100% (QA)

In United States ex rel Franklin v ParkeDavis The alleged false claim was related to the offlabel promotion of the drug Neurontin for uses not approve... View the full answer